Efficacy and Safety of Repaglinide Combined With Insulin in Type 2 Diabetes
Status:
Completed
Trial end date:
2003-04-10
Target enrollment:
Participant gender:
Summary
This trial is conducted in Asia. The aim of this trial is to compare oral anti-diabetic drug
(OAD) combined with insulin vs. insulin alone in subjects with type 2 diabetes not adequately
controlled on the current OAD therapy.